DAA2136 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
parietal lobe |
Human |
HLA-DRB1 |
90.3% Increase Gene Expression Level |
|
DAA2142 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
Molecular |
parietal lobe |
Human |
FCGR1A |
207.6% Increase Gene Expression Level |
|
DAA2143 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
Molecular |
parietal lobe |
Human |
FCGR1B |
225.5% Increase Gene Expression Level |
|
DAA2151 |
complement component 4A increases with age |
Molecular |
parietal lobe |
Human |
C4A |
153.8% Increase Gene Expression Level |
|
DAA2152 |
complement component 4B increases with age |
Molecular |
parietal lobe |
Human |
C4B |
444.8% Increase Gene Expression Level |
|
DAA2156 |
Major histocompatibility complex, class II, DQ alpha 1 increases with age |
Molecular |
parietal lobe |
Human |
HLA-DQA1 |
203.7% Increase Gene Expression Level |
|
DAA2158 |
complement factor H-related 1 increases with age |
Molecular |
parietal lobe |
Human |
CFHR1 |
126.5% Increase Gene Expression Level |
|
DAA2161 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
parietal lobe |
Human |
FCGR3B |
404.6% Increase Gene Expression Level |
|
DAA2164 |
major histocompatibility complex, class II, DR beta 6 increases with age |
Molecular |
parietal lobe |
Human |
HLA-DRB6 |
33.5% Increase Gene Expression Level |
|
DAA2181 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
parietal lobe |
Human |
C1QA |
154.9% Increase Gene Expression Level |
|
DAA2182 |
complement component 1, q subcomponent, B chain increases with age |
Molecular |
parietal lobe |
Human |
C1QB |
288.1% Increase Gene Expression Level |
|
DAA2183 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
parietal lobe |
Human |
C1QC |
216.2% Increase Gene Expression Level |
|
DAA2184 |
complement component 1, s subcomponent increases with age |
Molecular |
parietal lobe |
Human |
C1S |
54.0% Increase Gene Expression Level |
|
DAA2185 |
complement component 1, s subcomponent increases with age |
Molecular |
parietal lobe |
Human |
C1S |
60.4% Increase Gene Expression Level |
|
DAA2186 |
complement component 3 increases with age |
Molecular |
parietal lobe |
Human |
C3 |
108.4% Increase Gene Expression Level |
|
DAA2187 |
complement component 3a receptor 1 increases with age |
Molecular |
parietal lobe |
Human |
C3AR1 |
134.8% Increase Gene Expression Level |
|
DAA2188 |
complement component 5 increases with age |
Molecular |
parietal lobe |
Human |
C5 |
35.3% Increase Gene Expression Level |
|
DAA2189 |
complement component 5a receptor 1 increases with age |
Molecular |
parietal lobe |
Human |
C5AR1 |
34.3% Increase Gene Expression Level |
|
DAA2190 |
complement factor H increases with age |
Molecular |
parietal lobe |
Human |
CFH |
138.9% Increase Gene Expression Level |
|
DAA2191 |
Clusterin increases with age |
Molecular |
parietal lobe |
Human |
CLU |
22.5% Increase Gene Expression Level |
|
DAA2192 |
Clusterin increases with age |
Molecular |
parietal lobe |
Human |
CLU |
23.5% Increase Gene Expression Level |
|
DAA2193 |
Clusterin increases with age |
Molecular |
parietal lobe |
Human |
CLU |
47.9% Increase Gene Expression Level |
|
DAA2218 |
toll interacting protein decreases with age |
Molecular |
parietal lobe |
Human |
TOLLIP |
61.5% Decrease Gene Expression Level |
|
DAA2219 |
toll interacting protein decreases with age |
Molecular |
parietal lobe |
Human |
TOLLIP |
53.6% Decrease Gene Expression Level |
|
DAA2220 |
toll interacting protein decreases with age |
Molecular |
parietal lobe |
Human |
TOLLIP |
33.4% Decrease Gene Expression Level |
|